Context Therapeutics Inc.
CNTX
$2.36
-$0.12-4.84%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.85M | 7.67M | 7.66M | 7.44M | 7.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.70M | 30.21M | 38.30M | 31.63M | 29.92M |
| Operating Income | -39.70M | -30.21M | -38.30M | -31.63M | -29.92M |
| Income Before Tax | -36.12M | -26.44M | -34.21M | -27.63M | -26.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -36.12 | -26.44 | -34.21 | -27.63 | -26.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.12M | -26.44M | -34.21M | -27.63M | -26.73M |
| EBIT | -39.70M | -30.21M | -38.30M | -31.63M | -29.92M |
| EBITDA | -39.69M | -30.19M | -38.29M | -31.62M | -29.91M |
| EPS Basic | -0.38 | -0.28 | -0.40 | -0.35 | -0.53 |
| Normalized Basic EPS | -0.24 | -0.18 | -0.25 | -0.22 | -0.33 |
| EPS Diluted | -0.38 | -0.28 | -0.40 | -0.35 | -0.53 |
| Normalized Diluted EPS | -0.24 | -0.18 | -0.25 | -0.22 | -0.33 |
| Average Basic Shares Outstanding | 380.74M | 367.49M | 352.79M | 312.56M | 233.34M |
| Average Diluted Shares Outstanding | 380.74M | 367.49M | 352.79M | 312.56M | 233.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |